Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
LPSN vs CDLX: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
LPSN Wins Head-to-Head Institutional Verdict (4–2 across 6 Pillars · 7–3 Matrix Metrics)
LPSN Overall Winner
6-Pillar Tally: LPSN 4 – 2 CDLX
Matrix Metrics: LPSN 7 – 3 CDLX
As of Nov 20, 2026, LivePerson Inc (LPSN) is the stronger overall head-to-head candidate over Cardlytics, Inc. (CDLX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). LPSN carries a Unified Composite Score of 43.2/100 (HOLD) at $3.10 (19.3x Forward P/E, -31.6% operating margin), whereas CDLX carries 42.8/100 (HOLD) at $1.05 (36.5x Forward P/E, -19.3% operating margin).
- Technical & Structure Timing Caution: LPSN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 68.3); meanwhile CDLX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About LPSN vs CDLX
LPSN
Head-to-Head Winner
LivePerson Inc
$3.10
+0.0% 1D
Market Cap
$38.2M
TTM Revenue
$229M
Forward P/E
19.3x
Beta / 30D Vol
1.77β · 85% Vol
Unified Composite Score
43.2
HOLD
Tech 10.0
Fund 39.0
Flow 67.0
Mom 60.0
Weinstein Technical Phase
Markup · Hold / add on dips
CDLX
Cardlytics, Inc. Common Stock
$1.05
-5.41% 1D
Market Cap
$6.8M
TTM Revenue
$176M
Forward P/E
36.5x
Beta / 30D Vol
1.88β · 109% Vol
Unified Composite Score
42.8
HOLD
Tech 25.0
Fund 46.0
Flow 60.0
Mom 59.0
Weinstein Technical Phase
Markdown · Sell / avoid
6-Pillar Scorecard Institutional Category Breakdown (LPSN 4 – 2 CDLX)
1. Valuation Multiples
LPSN
Forward P/E
19.3x
36.5x
Trailing P/E
19.3x
36.5x
PEG Ratio
7.22x
N/M
EV / Revenue
0.2x
N/M
2. Growth & Scale
LPSN
Revenue Growth (YoY)
-11.9%
-30.0%
Earnings Growth (YoY)
+0.0%
-56.7%
TTM Revenue (USD)
$229M
$176M
Market Cap
$38.2M
$6.8M
3. Profitability & Quality
CDLX
Gross Margin
71.8%
49.7%
Operating Margin
-31.6%
-19.3%
Net Profit Margin
-51.9%
-20.8%
Return on Equity (ROE)
-598.7%
-513.2%
4. Balance Sheet & Cash Flow
LPSN
Cash Generation (TTM)
-$16M
-$16M
Cash Flow Margin
-7.1%
-9.2%
Net Cash / Leverage
-598.7% ROE
-513.2% ROE
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
LPSN
Options Structure Phase
CONSOLIDATION
BREAKDOWN
Current IV / %ile
71.2% (20th %ile)
0.8% (<1st %ile)
Put/Call OI Skew
N/A
0.01x (Call-Skewed)
OBV Trend / Tech Phase
ACCUMULATION · Markup
NEUTRAL · Markdown
6. R&D & Supply-Chain Moat
CDLX
OpEx & R&D Intensity
N/A
69.0% of Rev ($121M)
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
Cyclical / Execution-Driven Positioning
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Software - Application Operator
Advertising Agencies Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: LPSN (7) vs CDLX (3)| Institutional Metric | LPSN | CDLX | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $38.2M | $6.8M | LPSN | |
| Trailing P/E Ratio | 19.3x | 36.5x | LPSN | |
| Forward P/E Ratio | 19.3x | 36.5x | LPSN | |
| Revenue Growth (YoY) | -11.9% | -30.0% | LPSN | |
| Operating Margin (TTM) | -31.6% | -19.3% | CDLX | |
| Net Profit Margin | -51.9% | -20.8% | CDLX | |
| Return on Equity (ROE) | -598.7% | -513.2% | CDLX | |
| 52-Week Range Position | 38% ($0–$8) | 8% ($1–$6) | LPSN | |
| Beta / 30D Volatility | 1.77β · 85% Vol | 1.88β · 109% Vol | LPSN | |
| Unified Institutional Score | 43.2 / 100 (HOLD) | 42.8 / 100 (HOLD) | LPSN | |
| Trailing 12M Revenue (USD) | $229M | $176M | Scale | |
| Gross Profit Margin (TTM) | 71.8% | 49.7% | Quality | |
| PEG Ratio & EV / Revenue | 7.22x PEG · 0.2x EV/Rev | N/M PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$16M (-598.7% ROE) | -$16M (-513.2% ROE) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
LPSN +57.57 pp
3M Horizon
CDLX +459.45 pp
6M Horizon
CDLX +354.2 pp
1Y Horizon
CDLX +235.7 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | LPSN Revenue | CDLX Revenue | LPSN Op. Margin | CDLX Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $250M | $150M | -9.5% | -27.2% | LPSN |
| FY2019 | $290M | $210M | -29.8% | -8.2% | CDLX |
| FY2020 | $370M | $190M | -24.4% | -28.9% | LPSN |
| FY2021 | $470M | $260M | -19.9% | -47.4% | LPSN |
| FY2022 | $510M | $280M | -43.1% | -165.2% | LPSN |
| FY2023 | $400M | $290M | -27.7% | -47.5% | LPSN |
| FY2024 | $310M | $260M | -58.6% | -76.5% | LPSN |
| FY2025 | $240M | $210M | -32.3% | -48.0% | LPSN |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
LPSN
CONSOLIDATION
Current IV
71.2%
IV Percentile
20th %ile
Put/Call OI Skew
N/A
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
ACCUMULATION
Exact LPSN Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
CDLX
BREAKDOWN
Current IV
0.8%
IV Percentile
<1st %ile
Put/Call OI Skew
0.01x (Call-Skewed)
IV Regime
Compressed (<25th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact CDLX Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
LPSN Moat Profile
Cyclical / Execution-Driven Positioning
Software - Application Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
CDLX Moat Profile
Cyclical / Execution-Driven Positioning
Advertising Agencies Operator
OpEx & R&D Reinvestment
69.0% of Rev ($121M)
90D Engineering Disclosures
0 Published
Investor FAQ LPSN vs CDLX Key Questions & Quantitative Answers
As of Nov 20, 2026, LivePerson Inc (LPSN) is the stronger overall head-to-head candidate over Cardlytics, Inc. (CDLX) in the Tradestie Institutional Equity Comparison Engine, winning 7–3 core matrix metrics and 4–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Balance Sheet & Cash Flow). LPSN carries a Unified Composite Score of 43.2/100 (HOLD) at $3.10 (19.3x Forward P/E, -31.6% operating margin), whereas CDLX carries 42.8/100 (HOLD) at $1.05 (36.5x Forward P/E, -19.3% operating margin). Technical & Structure Timing Caution: LPSN trades in a Markup technical trend (CONSOLIDATION options phase, RSI 68.3); meanwhile CDLX is in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 22.6). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
LPSN leads the Growth & Scale pillar: LPSN posts -11.9% YoY revenue growth and +0.0% YoY earnings growth on $229M TTM revenue (71.8% gross margin, -31.6% operating margin), compared with CDLX at -30.0% YoY revenue growth and -56.7% YoY earnings growth on $176M TTM revenue (49.7% gross margin, -19.3% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), LPSN cumulative revenue shifted -4.0% while CDLX shifted +40.0%. In operating R&D and SG&A reinvestment, LPSN deploys N/A (0 90-day corporate R&D disclosures) versus 69.0% of Rev ($121M) (0 disclosures) for CDLX.
LPSN screens cheaper on headline valuation multiples. LPSN trades at 19.3x Forward P/E, 19.3x Trailing P/E, 7.22x PEG, and 0.2x EV/Revenue (-7.1% FCF margin), whereas CDLX trades at 36.5x Forward P/E, 36.5x Trailing P/E, N/M PEG, and N/M EV/Revenue (-9.2% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against LPSN (-598.7% ROE) versus CDLX (-513.2% ROE) capital efficiency.
In options market volatility and institutional positioning, LPSN carries 71.2% implied volatility (20th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, ACCUMULATION on-balance volume, and sits in a CONSOLIDATION options structure phase (1.77β · 85% Vol realized risk). By comparison, CDLX carries 0.8% implied volatility (<1st %ile, Compressed (<25th %ile)), a 0.01x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a BREAKDOWN options structure phase (1.88β · 109% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
CDLX vs LPSN · Reverse Pair
LPSN vs FIVN
· Sector Peer
LPSN vs RNG
· Sector Peer
LPSN vs HUCK
· Sector Peer
CDLX vs EVER
· Sector Peer
CDLX vs HUCK
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem